COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA

被引：0
|
作者：
Xuan, J. [1 ]
Lu, Y. [2 ]
Xuan, D. [3 ]
Fu, Y. [1 ]
机构：
[1] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China
[2] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China
[3] Univ N Carolina, Gillings Global Sch Publ Hlth, Chapel Hill, NC 27515 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.458
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV22
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial
    Singh, Kavita
    Crossan, Catriona
    Laba, Tracey-Lea
    Roy, Ambuj
    Hayes, Alison
    Salam, Abdul
    Jan, Stephen
    Lord, Joanne
    Tandon, Nikhil
    Rodgers, Anthony
    Patel, Anushka
    Thom, Simon
    Prabhakaran, Dorairaj
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 262 : 71 - 78
  • [32] Cost-effectiveness of valsartan versus amlodipine to treat microalbuminuria in diabetic patients: Economic analysis of the Marval trial
    Smith, DG
    Viberti, G
    Nguyen, A
    Frech, FH
    Yokoyama, K
    JOURNAL OF HYPERTENSION, 2004, 22 : S132 - S133
  • [33] Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis
    Woode, Maame Esi
    Wong, Kristina
    Reid, Christopher M.
    Stowasser, Michael
    Russell, Grant
    Gwini, Stellamay
    Young, Morag J.
    Fuller, Peter J.
    Yang, Jun
    Chen, Gang
    JOURNAL OF HYPERTENSION, 2023, 41 (10) : 1615 - 1625
  • [34] Clinic efficiency and cost-effectiveness analysis of structured education program for hypertensive patients in Russia
    Kontsevaya, A.
    Kalinina, A.
    Nazarova, O.
    JOURNAL OF HYPERTENSION, 2008, 26 : S51 - S51
  • [35] Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-line treatment for patients with hypertension: An ALLHAT analysis
    Heidenreich, PA
    Davis, BR
    Furberg, CD
    Lairson, DR
    Pressel, S
    Goldman, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 372A - 372A
  • [36] Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
    Chan, Ming-Cheng
    Tan, Elise Chia-Hui
    Yang, Ming-Chin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1079 - 1088
  • [37] Analysis of the cost-effectiveness of monotherapy versus fixed dose combination treatment of asthma in Republic of Moldova
    Corlateanu, Alexandru
    Botnaru, Victor
    Procoava, Ana
    Corlateanu, Olga
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [38] Screening for chronic kidney disease with microalbumin in hypertensive patients: A cost-effectiveness analysis.
    Berbano, E
    Abbott, K
    O'Malley, P
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 208 - 208
  • [39] COST-EFFECTIVENESS OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CHINA
    Wang, B. C.
    Chen, Y.
    Furnback, W.
    Wu, Q.
    Dong, P.
    VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [40] THE EFFECTS OF OLMESARTAN/AMLODIPINE ON METABOLIC AND INFLAMMATION MEDIATORS IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME ARE DOSE-DEPENDENT: THE OLAS STUDY
    Martinez Martin, F.
    JOURNAL OF HYPERTENSION, 2010, 28 : E107 - E108
12345